Rise Life Science Corp (RLSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 08-2021 | 05-2021 | 02-2021 | 11-2020 | 08-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 4 | 17 | 17 |
| Accounts receivable | -28 | 55 | 0 | -5 | 0 |
| Other Working Capital | 12 | 282 | 17 | -1,828 | 221 |
| Other Operating Activity | -102 | -452 | -25 | -135 | -248 |
| Operating Cash Flow | $-119 | $-116 | $-3 | $-1,952 | $-10 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 20 | 0 | N/A |
| Debt Repayment | N/A | N/A | 0 | -1 | -1 |
| Other Financing Activity | 119 | 32 | 0 | 1,925 | 0 |
| Financing Cash Flow | $119 | $32 | $20 | $1,924 | $-1 |
| Beginning Cash Position | 1 | 86 | 69 | 97 | 107 |
| End Cash Position | 2 | 1 | 86 | 69 | 97 |
| Net Cash Flow | $0 | $-84 | $17 | $-28 | $-10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -119 | -116 | -3 | -1,952 | -10 |
| Free Cash Flow | -119 | -116 | -3 | -1,952 | -10 |